TLDR
- General Mills delivered adjusted EPS of 64 cents, falling short of the 73-cent Wall Street consensus
- Revenue declined 8% from the prior year to $4.44 billion, narrowly exceeding the $4.41 billion forecast
- Organic revenue fell 3%, underperforming Nielsen-tracked global retail sales by approximately 1.5 percentage points
- Full-year guidance remains intact: organic revenue down 1.5%–2%, adjusted earnings down 16%–20%
- GIS shares declined 0.8% in premarket action and are down 17% year-to-date in 2026, with a 34%+ decline over 12 months
General Mills delivered third-quarter fiscal results on Wednesday that painted a challenging picture, with the company’s bottom-line performance missing Wall Street’s targets while revenue barely surpassed estimates. Management’s decision to maintain previously lowered guidance provided little comfort to shareholders.
The food giant’s adjusted earnings per share reached 64 cents, significantly below the Street’s 73-cent projection. Revenue, accounting for portfolio adjustments and transactions, decreased 8% compared to the same period last year, landing at $4.44 billion—just ahead of the $4.41 billion analyst forecast.
When examining organic revenue performance, the company saw a 3% decline—lagging behind Nielsen-tracked global retail sales data by about 1.5 percentage points. This disparity indicates the company is experiencing market share erosion beyond macroeconomic challenges.
Shares retreated 0.8% in early Wednesday trading. Before this report, GIS had already tumbled 17% in 2026 and shed more than 34% over the trailing twelve months, positioning it among the weakest performers within packaged food stocks.
Consumers Keep Choosing Cheaper Options
The underlying dynamics aren’t complex. Budget-conscious shoppers grappling with elevated living costs are increasingly selecting private-label and retailer-branded alternatives over established brands like Cheerios, Lucky Charms, and Pillsbury.
This consumer behavior shift has been accelerating for some time. Food manufacturers that aggressively pushed through price increases during the inflationary period are now confronting the consequences. General Mills finds itself squarely in this camp.
Additionally, consumer preferences are shifting away from heavily processed and packaged food products. The rapid mainstream adoption of GLP-1 weight-loss medications has intensified this trend, steering consumers toward modified consumption patterns.
Uncertainty surrounding consumer spending power—partially connected to geopolitical developments including the Iran war—has further dampened demand for traditional pantry items.
Full-Year Outlook Unchanged After Last Month’s Cut
General Mills maintained its full-year projections, though these forecasts had already been reduced last month. The company continues to anticipate organic net revenue will decline between 1.5% and 2% for the complete fiscal year.
Both adjusted operating profit and adjusted earnings per share are projected to drop 16% to 20% on a constant currency basis. This represents a significant deterioration, and investors have been absorbing this reality for several months.
The guidance confirmation did little to reassure the investment community. Between organic sales underperforming retail tracking data and the earnings shortfall compounding an already difficult period, Wednesday’s quarterly report offered few reasons for optimism.
The S&P 500 futures were trading 0.4% higher on Wednesday, with the broader index down 1.9% so far in 2026.
